60 DEGREES PHARMACEUTICALS, INC. (SXTPW) Gross margin 2022–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTPW) gross margin by fiscal year — reported gross profit divided by reported revenue.
22.3%FY2025 · since FY2022: -93.7% → 22.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 22.3% | -14.4 pp |
| FY2024 | 36.7% | +123.8 pp |
| FY2023 | -87.1% | +6.6 pp |
| FY2022 | -93.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTPW financial trends
SXTPW RevenueSXTPW Net incomeSXTPW Net marginSXTPW Gross profitSXTPW Operating incomeSXTPW Operating marginSXTPW Operating cash flowSXTPW Free cash flowSXTPW Capital expendituresSXTPW Return on equitySXTPW Stock buybacksSXTPW Dividends paidSXTPW Total assetsSXTPW Total liabilitiesSXTPW Shareholders’ equitySXTPW overview →